Concepedia
Statistics
Publications
42
Citations
2.3K
H-Index
25
Active since
2006
Affiliations
Hospices Civils de Lyon(Current)
Université Claude Bernard Lyon 1
Sorbonne Université
Hôpital Edouard Herriot
Assistance Publique – Hôpitaux de Paris
Laurent Pérard is an author at Hospices Civils de Lyon specializing in medicine, immunology, and life sciences.
Publications per year
2006–2024
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text
Life Sciences, Immunology, Internal Medicine +14
Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C–related mixed cryoglobulinemia
David Saadoun, Matthieu Resche‐Rigon, D. Sène et al. · Blood · 2010 · 262 citations · Full text
Pharmacy, Immunology, Pharmacotherapy +12
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
N. Costedoat‐Chalumeau, Lionel Galicier, O. Aumaître et al. · Annals of the Rheumatic Diseases · 2012 · 206 citations
Medicine, Pharmacology, Pharmacotherapy +15
Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network
Hélène Vallet, P. Sève, Lucie Biard et al. · Arthritis & Rheumatology · 2016 · 175 citations
Pharmacy, Immunology, Pharmacotherapy +16
Efficacy and tolerability of rituximab with or without PEGylated interferon alfa‐2b plus ribavirin in severe hepatitis C virus–related vasculitis: A long‐term followup study of thirty‐two patients
Benjamin Terrier, David Saadoun, D. Sène et al. · Arthritis & Rheumatism · 2009 · 110 citations
Pharmacy, Immunology, Pharmacotherapy +17
1–5 of 42